These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23724618)

  • 1. Atorvastatin therapy is not associated with slowing the progression of aortic stenosis: findings of a randomized controlled trial.
    Panahi Y; Sahebkar A; Taghipour HR; Dadjou Y; Pishgoo B; Rakhshankhah AS
    Clin Lab; 2013; 59(3-4):299-305. PubMed ID: 23724618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
    Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
    N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
    Novaro GM; Tiong IY; Pearce GL; Lauer MS; Sprecher DL; Griffin BP
    Circulation; 2001 Oct; 104(18):2205-9. PubMed ID: 11684632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg).
    Dichtl W; Alber HF; Feuchtner GM; Hintringer F; Reinthaler M; Bartel T; Süssenbacher A; Grander W; Ulmer H; Pachinger O; Müller S
    Am J Cardiol; 2008 Sep; 102(6):743-8. PubMed ID: 18774000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.
    Houslay ES; Cowell SJ; Prescott RJ; Reid J; Burton J; Northridge DB; Boon NA; Newby DE;
    Heart; 2006 Sep; 92(9):1207-12. PubMed ID: 16449511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
    Suleiman M; Koestler C; Lerman A; Lopez-Jimenez F; Herges R; Hodge D; Bradley D; Cha YM; Brady PA; Munger TM; Asirvatham SJ; Packer DL; Friedman PA
    Heart Rhythm; 2012 Feb; 9(2):172-8. PubMed ID: 21920481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Sharman JE; Coombes JS
    J Atheroscler Thromb; 2010 Mar; 17(3):235-41. PubMed ID: 20032570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
    Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
    Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and aortic stenosis progression: are biologic targets still an option?
    Pai RG
    Curr Cardiol Rep; 2005 Nov; 7(6):399-400. PubMed ID: 16256007
    [No Abstract]   [Full Text] [Related]  

  • 13. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statins on the progression of bioprosthetic aortic valve degeneration.
    Antonini-Canterin F; Zuppiroli A; Popescu BA; Granata G; Cervesato E; Piazza R; Pavan D; Nicolosi GL
    Am J Cardiol; 2003 Dec; 92(12):1479-82. PubMed ID: 14675593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
    Robinson JG; Nedergaard BS; Rogers WJ; Fialkow J; Neutel JM; Ramstad D; Somaratne R; Legg JC; Nelson P; Scott R; Wasserman SM; Weiss R;
    JAMA; 2014 May; 311(18):1870-82. PubMed ID: 24825642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for the treatment of dementia.
    McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007514. PubMed ID: 20687089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.
    Feldman HH; Doody RS; Kivipelto M; Sparks DL; Waters DD; Jones RW; Schwam E; Schindler R; Hey-Hadavi J; DeMicco DA; Breazna A;
    Neurology; 2010 Mar; 74(12):956-64. PubMed ID: 20200346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
    Davidson MH; Rosenson RS; Maki KC; Nicholls SJ; Ballantyne CM; Mazzone T; Carlson DM; Williams LA; Kelly MT; Camp HS; Lele A; Stolzenbach JC
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1298-306. PubMed ID: 24743431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.